We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+13.33%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$54.8B
AUM Growth
+$4.24B
Cap. Flow
-$502M
Cap. Flow %
-0.92%
Top 10 Hldgs %
29.94%
Holding
1,776
New
37
Increased
449
Reduced
1,142
Closed
51

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$158M
2
UBER icon
Uber
UBER
+$110M
3
BXSL icon
Blackstone Secured Lending
BXSL
+$97.3M
4
AMZN icon
Amazon
AMZN
+$76.3M
5
PYPL icon
PayPal
PYPL
+$75.8M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$184M
2
CCI icon
Crown Castle
CCI
+$173M
3
CME icon
CME Group
CME
+$125M
4
GILD icon
Gilead Sciences
GILD
+$119M
5
AMGN icon
Amgen
AMGN
+$115M

Sector Composition

Rank Sector Weight
1 Technology 28.81%
2 Healthcare 15.16%
3 Financials 13.11%
4 Consumer Discretionary 9.82%
5 Communication Services 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGFV
1726
DELISTED
Big 5 Sporting Goods
BGFV
– –
-44,388
Closed -$281K
CLNE icon
1727
Clean Energy Fuels
CLNE
$421M
– –
-147,370
Closed -$564K
ERAS icon
1728
Erasca
ERAS
$6.3B
– –
-50,000
Closed -$107K
GPCR icon
1729
Structure Therapeutics
GPCR
$3.4B
– –
-16,300
Closed -$664K
HCAT icon
1730
Health Catalyst
HCAT
$158M
– –
-456,841
Closed -$4.23M
HES
1731
DELISTED
Hess
HES
– –
-8,465
Closed -$1.22M
IWM icon
1732
iShares Russell 2000 ETF
IWM
$80.4B
– –
-325,000
Closed -$65.2M
JNPR
1733
DELISTED
Juniper Networks
JNPR
– –
-329,507
Closed -$9.71M
KNSA icon
1734
Kiniksa Pharmaceuticals
KNSA
$6.11B
– –
-66,443
Closed -$1.17M
KRON
1735
DELISTED
Kronos Bio
KRON
– –
-16,150
Closed -$20.2K
KURA icon
1736
Kura Oncology
KURA
$826M
– –
-71,742
Closed -$1.03M
KYMR icon
1737
Kymera Therapeutics
KYMR
$8.73B
– –
-40,207
Closed -$1.02M
MGRC icon
1738
McGrath RentCorp
MGRC
$2.95B
– –
-9,200
Closed -$1.1M
MNSO icon
1739
MINISO
MNSO
$3.73B
– –
-9,550
Closed -$195K
MURA
1740
DELISTED
Mural Oncology
MURA
– –
-43,759
Closed -$259K
NAMSW icon
1741
NewAmsterdam Pharma Warrant
NAMSW
$76.2M
– –
-150,000
Closed -$470K
NUVB icon
1742
Nuvation Bio
NUVB
$2.33B
– –
-63,763
Closed -$96.3K
PLUG icon
1743
Plug Power
PLUG
$2.73B
– –
-240,040
Closed -$1.08M
PRM icon
1744
Perimeter Solutions
PRM
$5.69B
– –
-28,668
Closed -$132K
QGEN icon
1745
Qiagen
QGEN
$8.72B
– –
-11,882
Closed -$530K
REPL icon
1746
Replimune Group
REPL
$449M
– –
-270,007
Closed -$2.28M
SABR icon
1747
Sabre
SABR
$743M
– –
-169,010
Closed -$744K
SPY icon
1748
State Street SPDR S&P 500 ETF Trust
SPY
$783B
– –
-140,000
Closed -$66.5M
SYBX
1749
DELISTED
Synlogic
SYBX
– –
-2,207
Closed -$8.5K
TU icon
1750
Telus
TU
$16.7B
– –
-58,383
Closed -$1.02M
67 68 69
70
71

Similar funds

Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
State Board of Administration of Florida Retirement System
State Board of Administration of Florida Retirement System Tallahassee, Florida $53.4B AUM 29.16% 1-Year Est. Return
Betterment LLC
Betterment LLC New York $52.8B AUM 15.34% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SCP
Soroban Capital Partners New York $51.8B AUM 21.41% 1-Year Est. Return

Ensign Peak Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Ensign Peak Advisors held 1,776 positions worth $54.8B, up 8.4% from $50.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 5%. Ensign Peak Advisors opened 37 new positions and exited 51, leaving the 1,776-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q1 2024 buy was Blackstone Secured Lending: 3,319,725 shares worth $103M.
  • Ensign Peak Advisors added most to Eli Lilly in Q1 2024, an estimated $158M increase.
  • Ensign Peak Advisors's biggest Q1 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $184M.
  • Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $66.5M.
  • Ensign Peak Advisors's ten largest holdings make up 30% of its $54.8B portfolio in Q1 2024.
  • Ensign Peak Advisors opened 37 new positions and closed 51 in Q1 2024.
  • Ensign Peak Advisors's portfolio value rose 8.4% quarter-over-quarter to $54.8B.

Based on Ensign Peak Advisors's 13F filing for Q1 2024, filed 14 May 2024.